Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants

NCT06190678 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Renal Insufficiency

Interventions

DRUG: Pirtobrutinib

Sponsor

Eli Lilly and Company

Collaborators

[object Object]